SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-23-001595
Filing Date
2023-06-28
Accepted
2023-06-28 16:32:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da110680014_06282023.htm SC 13D/A 205148
2 JOINT FILING AGREEMENT ex991to13da110680014_062823.htm EX-99.1 10969
  Complete submission text file 0000921895-23-001595.txt   217670
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Subject) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: SC 13D/A | Act: 34 | File No.: 005-45181 | Film No.: 231052658
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107
Business Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107 206-227-3078
22NW Fund, LP (Filed by) CIK: 0001640809 (see all company filings)

IRS No.: 473303449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A